Showing results (31-40 of 301) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2003
Myasthenic syndrome caused by mutation of the SCN4A sodium channelAkira Tsujino, Chantal Maertens, Kinji Ohno, et al.
Neurology|June 25, 2013
GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneityDuygu Selcen, Xin-Ming Shen, Margherita Milone, et al.
Annals of Nutrition & Metabolism|September 9, 2021
Parkinson's Disease and Gut MicrobiotaMasaaki Hirayama, Kinji Ohno
Matrix Biology : Journal of the International Society for Matrix Biology|February 24, 2018
Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinationsMikako Ito, Kinji Ohno
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 9, 2022
[Ascendance of Abnormal α-synuclein Fibrils Through the Vagal Nerve in Parkinson's Disease]Kinji Ohno, Masaaki Hirayama
Journal of Human Genetics|March 25, 2016
IntSplice: prediction of the splicing consequences of intronic single-nucleotide variations in the human genomeAkihide Shibata, Tatsuya Okuno, Mohammad Alinoor Rahman, et al.
Scientific Reports|August 19, 2015
SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndromeMohammad Alinoor Rahman, Yoshiteru Azuma, Farhana Nasrin, et al.
Scientific Reports|September 11, 2015
Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signalingKenji Otsuka, Mikako Ito, Bisei Ohkawara, et al.
Human Molecular Genetics|November 16, 2013
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific mannerBisei Ohkawara, Macarena Cabrera-Serrano, Tomohiko Nakata, et al.
Pageof 31